ACADIA Pharmaceuticals Inc. (ACAD) stock is down -56.49% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ACAD stock a score of 32 out of a possible 100. That rank is primarily influenced by a long-term technical score of 6. ACAD's rank also includes a short-term technical score of 19. The fundamental score for ACAD is 70. In addition to the average rating from Wall Street analysts, ACAD stock has a mean target price of $25.80. This means analysts expect the stock to rise 56.46% over the next 12 months.
News Home
ACADIA Pharmaceuticals Inc. (ACAD) Stock Loses -6.78% This Week; Should You Buy?
Mentioned in this article
ACAD has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ACAD!